Final report of the Lyme disease review panel of the Infectious Diseases Society of America
- PMID: 20504239
- DOI: 10.1086/654809
Final report of the Lyme disease review panel of the Infectious Diseases Society of America
Abstract
In April 2008, the Infectious Diseases Society of America (IDSA) entered into an agreement with Connecticut Attorney General Richard Blumenthal to voluntarily undertake a special review of its 2006 Lyme disease guidelines. This agreement ended the Attorney General's investigation into the process by which the guidelines were developed. The IDSA agreed to convene an independent panel to conduct a one-time review of the guidelines. The Review Panel members, vetted by an ombudsman for potential conflicts of interest, reviewed the entirety of the 2006 guidelines, with particular attention to the recommendations devoted to post-Lyme disease syndromes. After multiple meetings, a public hearing, and extensive review of research and other information, the Review Panel concluded that the recommendations contained in the 2006 guidelines were medically and scientifically justified on the basis of all of the available evidence and that no changes to the guidelines were necessary.
Comment in
-
Final report of the Lyme disease review panel of the infectious diseases society of america: a pyrrhic victory?Clin Infect Dis. 2010 Nov 1;51(9):1108-9; author reply 1109-1. doi: 10.1086/656690. Clin Infect Dis. 2010. PMID: 20925511 No abstract available.
Similar articles
-
Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process.J Med Ethics. 2009 May;35(5):283-8. doi: 10.1136/jme.2008.026526. J Med Ethics. 2009. PMID: 19407031
-
In the lymelight: law and clinical practice guidelines.South Med J. 2009 Jun;102(6):626-30. doi: 10.1097/SMJ.0b013e3181a5dcce. South Med J. 2009. PMID: 19434013 Review.
-
Clarification of the Agreement between the Infectious Diseases Society of America and the Attorney General of Connecticut.Clin Infect Dis. 2008 Nov 1;47(9):1200. doi: 10.1086/592248. Clin Infect Dis. 2008. PMID: 18823267 No abstract available.
-
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.J Med Ethics. 2011 Feb;37(2):68-73. doi: 10.1136/jme.2009.032896. Epub 2010 Nov 21. J Med Ethics. 2011. PMID: 21097940
-
[The modern therapy of lyme disease].Przegl Epidemiol. 2007;61(3):449-56. Przegl Epidemiol. 2007. PMID: 18069380 Review. Polish.
Cited by
-
Differentiating Psychosomatic, Somatopsychic, Multisystem Illnesses, and Medical Uncertainty.Healthcare (Basel). 2019 Oct 8;7(4):114. doi: 10.3390/healthcare7040114. Healthcare (Basel). 2019. PMID: 31597359 Free PMC article. Review.
-
Lymelight: forecasting Lyme disease risk using web search data.NPJ Digit Med. 2020 Feb 4;3:16. doi: 10.1038/s41746-020-0222-x. eCollection 2020. NPJ Digit Med. 2020. PMID: 32047861 Free PMC article.
-
International consensus on periprosthetic joint infection: description of the consensus process.Clin Orthop Relat Res. 2013 Dec;471(12):4065-75. doi: 10.1007/s11999-013-3329-4. Epub 2013 Oct 24. Clin Orthop Relat Res. 2013. PMID: 24155178 Free PMC article. No abstract available.
-
Guidelines 2.0: do no net harm-the future of practice guideline development in asthma and other diseases.Curr Allergy Asthma Rep. 2011 Jun;11(3):261-8. doi: 10.1007/s11882-011-0185-8. Curr Allergy Asthma Rep. 2011. PMID: 21409613 Review.
-
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.Clin Infect Dis. 2018 Aug 31;67(6):e1-e94. doi: 10.1093/cid/ciy381. Clin Infect Dis. 2018. PMID: 29955859 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous